Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

Navitor Approval Study Outcomes & Best Practices

Presenter: Ibrahim Sultan

June 09, 2023

Presentation TVT 2023

Contemporary, Core-Lab Assessed, Acute Clinical Outcomes from 2000+ Patients with Mitral Regurgitation Treated with the 3rd and 4th Generation MitraClip™ Systems: Results from the EXPANDed Post Approval Studies

Presenter: Matthew Price

June 08, 2023

Presentation TVT 2023

Analysis of Procedure Volume and Outcomes of Surgical and Transcatheter Aortic Valve Replacement Following Regulatory Approval of Low-Surgical Risk Patients

Presenter: Ghadi Moubarak

June 08, 2023

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

Presentation TVT 2022

Post-Approval Safety Profile of Amulet vs Watchman FLX Left Atrial Appendage Closure Devices: Analysis from the MAUDE Database (ALERT-MAUDE Study)

Presenter: Poonam Velagapudi

June 10, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

News Conference News TVT 2021

New-Generation Watchman FLX Maintains Good Results Through 2 Years

Todd Neale

July 28, 2021

News Conference News TVT 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

Todd Neale

July 23, 2021

News Conference News TVT 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

Todd Neale

July 22, 2021

News Conference News TVT 2020

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Shelley Wood

June 24, 2020

News Conference News TVT 2020

Newer TAVR Devices Reassure in Failed Surgical Valves

Shelley Wood

June 20, 2020

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

Low-Risk Approval: Who Isn’t a Candidate for TAVR?

Presenter: Tsuyoshi Kaneko

June 12, 2019

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

News Conference News TVT 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

Advertisement

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Navitor Approval Study Outcomes & Best Practices

Contemporary, Core-Lab Assessed, Acute Clinical Outcomes from 2000+ Patients with Mitral Regurgitation Treated with the 3rd and 4th Generation MitraClip™ Systems: Results from the EXPANDed Post Approval Studies

Analysis of Procedure Volume and Outcomes of Surgical and Transcatheter Aortic Valve Replacement Following Regulatory Approval of Low-Surgical Risk Patients

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Post-Approval Safety Profile of Amulet vs Watchman FLX Left Atrial Appendage Closure Devices: Analysis from the MAUDE Database (ALERT-MAUDE Study)

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

New-Generation Watchman FLX Maintains Good Results Through 2 Years

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Newer TAVR Devices Reassure in Failed Surgical Valves

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Low-Risk Approval: Who Isn’t a Candidate for TAVR?

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content